High‐resolution MR neurography follow‐up of SARS‐CoV‐2 vaccination‐associated neuralgic amyotrophy

• Published in: Annals of clinical and translational neurology Vol. 10; no. 12; pp. 2421 - 2425
• Main Authors: Mooshage, Christoph M., Kele, Henrich, Bendszus, Martin, Schwarz, Daniel
• Format: Journal Article
• Language: English
• Published: United States John Wiley & Sons, Inc 01.12.2023; Wiley
• Subjects: Brachial plexus; Brachial Plexus Neuritis - diagnostic imaging; Brachial Plexus Neuritis - etiology; COVID-19 - prevention & control; COVID-19 Vaccines - adverse effects; Denervation; Edema; Electromyography; Female; Follow-Up Studies; Humans; Immunization; Magnetic Resonance Imaging - methods; Male; Pain; Paresis; Patients; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Vaccines
• ISSN: 2328-9503; 2328-9503
• DOI: 10.1002/acn3.51916

Little is known about the value of high‐resolution follow‐up imaging in patients with neuralgic amyotrophy (NA) and the question of the best treatment algorithm remains unclear. Three patients (one female, two male) with the clinical presentation of SARS‐CoV‐2‐vaccination‐associated NA underwent initial magnetic resonance neurography (MRN) imaging and follow‐up examinations. All patients showed a marked clinical improvement, independent of treatment, including an almost full recovery of motor function over the course of 8–12 months which was accurately mirrored by imaging findings on MRN. MRN imaging is a valuable tool for monitoring the further clinical course of patients suffering from vaccination‐associated NA.